EDCTP aims to enhance research capacity and accelerate the development of new or improved health technologies for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including emerging and re-emerging diseases in sub-Saharan Africa, through all phases of clinical trials, with emphasis on phase II and III trials.
Established in 2021, the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking builds on the first and second EDCTP programmes. It is a partnership between the EU and the EDCTP Association, whose members are several European and African countries.
The partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.